With the rise of hit drugs like GLP-1 agonists and biologics requiring specialised packaging considerations, the strain of meeting sustainability and patient-centric goals, all while balancing costs, time, and efficiency, the pharmaceutical packaging sector is gearing up for valuable opportunities to ...
With the rise of hit drugs like GLP-1 agonists and biologics requiring specialised packaging considerations, the strain of meeting sustainability and patient-centric goals, all while balancing costs, time, and efficiency, the pharmaceutical packaging sector is gearing up for valuable opportunities to ...